沛嘉醫療-B(09996.HK)對Sutra Medical進行戰略投資
沛嘉醫療-B(09996.HK)公布,旗下全資附屬沛嘉蘇州與Sutra Medical以及若干其他方簽訂了一份股份購買協議,並已將其於股份購買協議項下的所有權利及責任轉讓予其全資附屬公司Peijia Holding。
Sutra Medical成立於2012年,目前總部位於加州森林湖,其設計並開發了治療經導管心臟病的解決方案。
Peijia Holding買賣Sutra Medical股份的初步交易於2021年8月完成,Peijia Holding目前為Sutra Medical的第二大股東,僅次於Sutra Medical創始團隊。根據該協議,達致若干里程碑後,Peijia Holding將購買Sutra Medical的若干額外股份。此外,倘Sutra Medical擬發售或出售任何新證券,公司在受限於若干例外情況下可享有優先購買權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.